lymphocyte expansion molecule stimulator gene therapy (ImmunarT)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namelymphocyte expansion molecule stimulator gene therapy (ImmunarT)
Drug Alias NameLEM stimulator gene therapy (ImmunarT)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasmsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunarT Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunarT Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasmsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A